Literature DB >> 26897303

Risk Factors and Clinical Significance of Lymphopenia in Survivors of the Fontan Procedure for Single-Ventricle Congenital Cardiac Disease.

Megan M Morsheimer1, Jack Rychik2, Lisa Forbes3, Kathryn Dodds2, David J Goldberg2, Kathleen Sullivan1, Jennifer R Heimall4.   

Abstract

BACKGROUND: Congenital cardiac anomalies are associated with immunologic perturbations. Surgical thymectomy, thoracic duct manipulation, and protein- losing enteropathy (PLE), a condition related to stressed Fontan hemodynamics, presumably contribute to low peripheral absolute lymphocyte counts (ALCs) and quantitative immunoglobulins. Clinical significance of lymphopenia and hypogammaglobulinemia in single-ventricle survivors requires additional study.
OBJECTIVE: Although immunologic laboratory anomalies are common in this population, we hypothesize that clinically significant immunodeficiency requiring intervention is rarely required.
METHODS: A retrospective chart review of the immunologic parameters of patients enrolled in the Single Ventricle Survivorship Program (SVSP) at the Children's Hospital of Philadelphia was performed.
RESULTS: The age range of the 178 SVSP patients was 3 to 26 years, with a median of 10.8 years. Most of the SVSP patients had some degree of lymphopenia. In the non-PLE group, the range of ALCs varied from 530 to 5322 cells/μL, with 17 patients without PLE maintaining an ALC of less than 1000 cells/μL. Among those with PLE, the median ALC and the IgG level were lower (672 cells/μL and 200 mg/dL, respectively) than in those without (1610 cells/μL and 868 mg/dL, respectively). Despite lymphopenia in the majority, few were severely clinically affected: 24% had delayed clearance of cutaneous viral infections, 63% had atopy, and 1 died of EBV-associated Hodgkin lymphoma. Immunoglobulin replacement was clinically indicated for 3 patients, 1 of whom had common variable immunodeficiency. Four patients with normal splenic function were treated with daily antibiotic prophylaxis.
CONCLUSIONS: Patients with repaired single-ventricle physiology often demonstrate T-cell lymphopenia and hypogammaglobulinemia. A significant portion of patients without PLE also have lymphopenia. The most common clinical manifestation was delayed clearance of cutaneous viral infections, but significant systemic opportunistic infections were not seen despite laboratory abnormalities and lack of antimicrobial prophylaxis.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Fontan; Hypogammaglobulinemia; Protein-losing enteropathy (PLE); Secondary immunodeficiency; Single ventricle; T-cell lymphopenia; Warts

Mesh:

Year:  2016        PMID: 26897303     DOI: 10.1016/j.jaip.2015.11.034

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


  7 in total

Review 1.  A Path FORWARD: Development of a Comprehensive Multidisciplinary Clinic to Create Health and Wellness for the Child and Adolescent with a Fontan Circulation.

Authors:  Jack Rychik; David J Goldberg; Elizabeth Rand; Edna E Mancilla; Jennifer Heimall; Nicholas Seivert; Danielle Campbell; Shannon O'Malley; Kathryn M Dodds
Journal:  Pediatr Cardiol       Date:  2022-05-23       Impact factor: 1.838

2.  T-cell lymphopenia in 22q11.2 deletion syndrome: Relationship to cardiac disease.

Authors:  Kathleen E Sullivan; T Blaine Crowley; Kelly Maurer; Elizabeth Goldmuntz; J William Gaynor; Elaine Zackai; Donna McDonald-McGinn
Journal:  J Allergy Clin Immunol Pract       Date:  2017-09-28

3.  M281, an Anti-FcRn Antibody: Pharmacodynamics, Pharmacokinetics, and Safety Across the Full Range of IgG Reduction in a First-in-Human Study.

Authors:  Leona E Ling; Jan L Hillson; Renger G Tiessen; Tjerk Bosje; Mattheus Paulus van Iersel; Darrell J Nix; Lynn Markowitz; Nicholas A Cilfone; Jay Duffner; James B Streisand; Anthony M Manning; Santiago Arroyo
Journal:  Clin Pharmacol Ther       Date:  2018-12-04       Impact factor: 6.875

Review 4.  The pathophysiology and complications of Fontan circulation.

Authors:  Giuseppe Antonio Mazza; Elena Gribaudo; Gabriella Agnoletti
Journal:  Acta Biomed       Date:  2021-11-03

5.  COVID-19 vaccination in adults with congenital heart disease: Real-world data from an Italian tertiary centre.

Authors:  Flavia Fusco; Giancarlo Scognamiglio; Assunta Merola; Anna Selvaggia Roma; Carmine Nicastro; Micaela Spatarella; Maurizio D'Abbraccio; Gabriella Di Mauro; Umberto Atripaldi; Lidia Atripaldi; Anna Correra; Michela Palma; Rosaria Barracano; Nunzia Borrelli; Annalisa Capuano; Berardo Sarubbi
Journal:  Int J Cardiol Congenit Heart Dis       Date:  2021-10-28

6.  Fontan Circulation Associated Organ Abnormalities Beyond the Heart, Lungs, Liver, and Gut: A Systematic Review.

Authors:  Evi Ritmeester; Veerle A Veger; Jelle P G van der Ven; Gabrielle M J W van Tussenbroek; Carine I van Capelle; Floris E A Udink Ten Cate; Willem A Helbing
Journal:  Front Cardiovasc Med       Date:  2022-03-22

Review 7.  Targeting FcRn for immunomodulation: Benefits, risks, and practical considerations.

Authors:  Hans-Hartmut Peter; Hans D Ochs; Charlotte Cunningham-Rundles; Donald C Vinh; Peter Kiessling; Bernhard Greve; Stephen Jolles
Journal:  J Allergy Clin Immunol       Date:  2020-09       Impact factor: 10.793

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.